Allspring Global Investments’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $157K | Sell |
15,938
-860
| -5% | -$8.5K | ﹤0.01% | 1564 |
|
|
2025
Q1 | $112K | Buy |
16,798
+3,935
| +31% | +$26.2K | ﹤0.01% | 1690 |
|
|
2024
Q4 | $157K | Buy |
12,863
+1,582
| +14% | +$19.3K | ﹤0.01% | 1692 |
|
|
2024
Q3 | $232K | Buy |
11,281
+394
| +4% | +$8.1K | ﹤0.01% | 1650 |
|
|
2024
Q2 | $244K | Buy |
10,887
+1,993
| +22% | +$44.6K | ﹤0.01% | 1670 |
|
|
2024
Q1 | $245K | Buy |
8,894
+750
| +9% | +$20.6K | ﹤0.01% | 1663 |
|
|
2023
Q4 | $248K | Buy |
8,144
+582
| +8% | +$17.7K | ﹤0.01% | 1651 |
|
|
2023
Q3 | $239K | Sell |
7,562
-107
| -1% | -$3.38K | ﹤0.01% | 1714 |
|
|
2023
Q2 | $313K | Buy |
7,669
+3,393
| +79% | +$138K | ﹤0.01% | 1678 |
|
|
2023
Q1 | $159K | Sell |
4,276
-816
| -16% | -$30.4K | ﹤0.01% | 1879 |
|
|
2022
Q4 | $178K | Sell |
5,092
-65
| -1% | -$2.27K | ﹤0.01% | 1859 |
|
|
2022
Q3 | $288K | Sell |
5,157
-293
| -5% | -$16.4K | ﹤0.01% | 1710 |
|
|
2022
Q2 | $282K | Sell |
5,450
-25,046
| -82% | -$1.3M | ﹤0.01% | 1723 |
|
|
2022
Q1 | $2.22M | Sell |
30,496
-1,520
| -5% | -$110K | ﹤0.01% | 1452 |
|
|
2021
Q4 | $3.79M | Buy |
+32,016
| New | +$3.79M | ﹤0.01% | 1275 |
|